Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03764514 · ClinicalTrials.gov registry record

Spinal Cord Stimulation in Chemotherapy Induced Neuropathy

A clinical trial of Chemotherapy-induced Peripheral Neuropathy, sponsored by Prisma Health-Upstate.

Completed
Registry status
5
Enrollment target
1
Study location

NCT03764514 is a study of Chemotherapy-induced Peripheral Neuropathy that has completed, run by Prisma Health-Upstate. The registered enrollment target is 5 participants, below the 138-participant average among 29 other Chemotherapy-induced Peripheral Neuropathy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03764514, a study of Chemotherapy-induced Peripheral Neuropathy, has completed, sponsored by Prisma Health-Upstate.

COMPLETED
Registry status
5 participants
Enrollment target
1
Study location

Study Summary

This is an observational based pilot study evaluating the use of spinal cord stimulators for the treatment of chemotherapy induced peripheral neuropathy will lead to an increase in quality of life and decrease in pain.

Conditions Studied

Chemotherapy-induced Peripheral Neuropathy

Interventions

  • DEVICE Spinal Cord Stimulator

Study Locations (1)

South Carolina

  • Patewood Memorial Hospital - Greenville

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2018-12-03
Est. Completion 2022-05-03

Sponsor

Prisma Health-Upstate

67 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03764514

The ClinicalTrials.gov registry entry for NCT03764514 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 138-participant average among 29 other Chemotherapy-induced Peripheral Neuropathy trials with a reported enrollment target (96% lower). The listed sponsor is Prisma Health-Upstate, which has 67 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chemotherapy-induced Peripheral Neuropathy appearing as the primary indexed condition, and to 1 intervention - of which Spinal Cord Stimulator is the first listed.

NCT03764514 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT03764514 about?

NCT03764514 is a clinical study titled "Spinal Cord Stimulation in Chemotherapy Induced Neuropathy". This is an observational based pilot study evaluating the use of spinal cord stimulators for the treatment of chemotherapy induced peripheral neuropathy will lead to an increase in quality of life and decrease in pain.

What is the current status of trial NCT03764514?

This trial is currently completed. The enrollment target is 5 participants. The study started on 2018-12-03. Estimated completion is 2022-05-03.

What conditions does trial NCT03764514 study?

This clinical trial studies the following conditions: Chemotherapy-induced Peripheral Neuropathy.

What interventions are being tested in trial NCT03764514?

The interventions under investigation include: Spinal Cord Stimulator (DEVICE).

Who is sponsoring clinical trial NCT03764514?

This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03764514 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chemotherapy-induced Peripheral Neuropathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chemotherapy-induced Peripheral Neuropathy

All registered trials for this condition

South Carolina

All trials with a study site in South Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.